Less than two years after its IPO and months after shutting down its once-promising oncology program, Seattle-based Silverback Therapeutics will… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.